WO1995007729A1 - Device for stimulating the natural defenses of a person or of any cellular system - Google Patents
Device for stimulating the natural defenses of a person or of any cellular system Download PDFInfo
- Publication number
- WO1995007729A1 WO1995007729A1 PCT/EP1994/002842 EP9402842W WO9507729A1 WO 1995007729 A1 WO1995007729 A1 WO 1995007729A1 EP 9402842 W EP9402842 W EP 9402842W WO 9507729 A1 WO9507729 A1 WO 9507729A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- frequency
- oscillators
- mhz
- cellular system
- cell
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
Definitions
- the object of this invention is a device for stimulating the natural defenses of a person or of any cellular system, characterized by means for generating alternately electrical, magnetic and electromagnetic fields, at overlapping or sequentially ordered levels, with programmed modulations for creating therapeutic energy according to a certain code which resonates with the set of subatomic, atomic, molecular and cellular natural oscillators of an individual or of any cellular system, thus re- establishing metabolic equilibrium.
- the device creates the optimum electromagnetic environment for improving the development and functioning of any cell, whether a human, animal or plant cell.
- the device provides vital energy which, for many and sundry reasons, can become depleted. When this occurs, energy is transferred to those cells which need it, using very weak electromagnetic pulses which are virtually harmless to everyone.
- this device re-establishes cellular metabolism and thus also the metabolism of the entire ailing organism, creating—especially for the ailing elderly—a general sense of well-being, and improving general physiological activity by 90-100%.
- the device is also especially suitable for curing nerve, osteoarticular, arthritic, respiratory, blood, diabetic, and other disorders.
- Figure 1 shows the schematic of the device
- FIG. 2 is a block diagram. Descriptions follow which explain the device with regard to its conception.
- the basic conceptual principle is that of "recharging" the cellular unit.
- the transport, conversion and amplification of the signal received will allow the tissue cell or cells to respond in an appropriate manner, according to need.
- the initial composition that is, the receiving molecule present on the surface of the cell, transmits the information over the plasma membrane and inside this cell, by means of a family of proteins which function as transducers, called G proteins.
- G proteins activate an amplifier enzyme which is only located in the cell membrane; this transforms the precursor molecules into secondary messengers which spread out through the cell.
- the secondary messengers trigger some cellular proteins to modify their structure, with the result that the functioning of these proteins is activated or deactivated.
- the secondary messengers therefore, turn on or turn off the switches which control the activity of proteins, creating different conditions inside the cell. These conditions will determine the type of response the cell will give to signals received from the outside.
- the secondary messenger bonds to a component of an enzymatic protein, triggering the activity of the component which carries out enzyme functions.
- the mechanisms of signal transport and amplification are not necessary, while turning on or turning off the switch is done by the bond of the external signal.
- the action of receivers which have bonded the messenger can consist in selective opening of small pores or channels specific to given ions (for example, calcium) present in the cellular membrane.
- fat-soluble molecules steroid hormones
- the receivers for these hormones are located in the cytoplasm.
- proteins whose form is modified by the bond with the signal molecule.
- the modified protein enters the nucleus and becomes able to bond to DNA, the large molecule which preserves genetic information, at certain points, where it serves to control activation of the genes present at the point at which it is bound.
- This effect is known as primary response, in other cases secondary response, that is, the products of the primary response can have as a function—by bonding to DNA—that of activating other genes, amplifying and varying the response.
- Another method of controlling the response is to act on the receivers. After the water-soluble hormones bond with the appropriate receivers on the surface of the target cell, the cells often ingest them by endocytosis and destroy them. In this way, since there are either the same number or a lesser number of receivers, the capacity to respond to the hormones is also diminished.
- the receiver is "internalized” by endocytosis and preserved in vesicles, to be then reassembled on the cell membrane.
- Figure 1 shows the schematic of the device.
- the integrated circuit marked as IC2 acts as a pulse divider, and is a 12-stage binary device of the CMOS type.
- the integrated circuit marked as IC1 functions as a square wave oscillator, sending its composite signal to pin 10 of integrated circuit IC2, enabling the latter to generate from outputs 1-15-14-12-13 the proper stop/start pulses.
- the pulses will be spaced out by switch SI, which will make it possible, through passage of C18, to distinguish the signal coming from pin 5 of 1C1B.
- IC1D is amplified by the VHF power transistor, marked as TR4.
- TR4 VHF power transistor
- the output frequencies of transistors TRI and TR2 are matched by impedances IMP1 and IMP2 to a single intermediate frequency which will center on 12 MHz. From transistors TRI and TR2, which function as sequential power oscillators, it is possible to obtain, by continuous emissions, those which cover a frequency range from 20 to around 350 MHz. This type of "complex" wave will generate a considerable number of harmonics, since the emission will be modulated both in amplitude and in frequency.
- the passband which operates at a linear recurrence frequency, is around 100 MHz, and can generate much higher frequencies, emitting nonlinear square waves, with composite harmonics emitted which can reach 500 MHz.
- the two monostable adjustable oscillators at the NOR outputs of IC3 control the visual signal at the output through capacitors C13 and C17 by means of two LED diodes, marked on the diagram as DL1 and DL2 respectively.
- diodes DI and D2 as well as diodes D5 and D6 function as rectifiers of VHF signals, thus providing immediate display of the frequency intervals preselected, through switch SI.
- the circuit is powered with stabilized 24V direct current, with a maximum absorption of 30/35 mA.
- the device is installed in connection with a EUROCARD type card with dimensions of 100 x 160 mm.
- the 64-pin DIN 41612 on two wires is used as a terminal connector.
- the card marked with the designation 9301/M is installed in a standard 19" holder with a height equal to 3 units.
- Figure 2 shows a block diagram in which C is the converter, I.F. is the amplifier, M the modulator, A.F. the amplifier, 0 the oscillator.
- the signal is coded with n bits (0 or 1) , in fact is quantized in 2n levels.
- the time function which represents the signal, is sampled through the amplifier of F.I., while the amplitude of each sample is rounded off to the nearest of 2n levels admitted for transmission.
- the code used is binary code.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU76558/94A AU7655894A (en) | 1993-09-13 | 1994-08-27 | Device for stimulating the natural defenses of a person or of any cellular system |
EP94926898A EP0669843A1 (en) | 1993-09-13 | 1994-08-27 | Device for stimulating the natural defenses of a person or of any cellular system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH272893 | 1993-09-13 | ||
CH02728/93-0 | 1993-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995007729A1 true WO1995007729A1 (en) | 1995-03-23 |
Family
ID=4240274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1994/002842 WO1995007729A1 (en) | 1993-09-13 | 1994-08-27 | Device for stimulating the natural defenses of a person or of any cellular system |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0669843A1 (en) |
AU (1) | AU7655894A (en) |
WO (1) | WO1995007729A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997013549A1 (en) * | 1995-10-10 | 1997-04-17 | Suleyman Seckiner Gorgun | Device and process for the modulation of the biological functions of biological structures |
WO2001070334A1 (en) * | 2000-03-24 | 2001-09-27 | Active Medical Devices S.A. | Equipment designed to stimulate and optimise the biomolecular and cellular reorganization |
FR2820327A1 (en) * | 2001-02-06 | 2002-08-09 | Mohamed Ayari | PROCESS FOR OBTAINING A SET OF ELECTROMAGNETIC FIELDS WITH DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND BIOTECHNOLOGICAL VIEWS |
AU751973B2 (en) * | 1997-10-17 | 2002-09-05 | Axel Muntermann | Device for magnetic field therapy |
WO2019178704A1 (en) * | 2018-03-20 | 2019-09-26 | Novatech - Solutions Sa | Equipment designed to stimulate and optimize the bio-molecular and cellular reorganization |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0136530A1 (en) * | 1983-09-12 | 1985-04-10 | Dieter-Ernst Broers | Irradiation device for treating living tissue with electro-magnetic waves |
US4611599A (en) * | 1983-06-16 | 1986-09-16 | Richard Hugh Cameron Bentall | Electrical apparatus for influencing the metabolic characteristics of living systems |
CH667210A5 (en) * | 1981-11-24 | 1988-09-30 | Meguer V Kalfaian | Electromagnetic radiation device for therapeutic purposes. |
EP0500983A1 (en) * | 1991-02-28 | 1992-09-02 | Medi-Line Gmbh | Irradiation device for treating living tissue with electro-magnetic waves |
-
1994
- 1994-08-27 WO PCT/EP1994/002842 patent/WO1995007729A1/en not_active Application Discontinuation
- 1994-08-27 AU AU76558/94A patent/AU7655894A/en not_active Abandoned
- 1994-08-27 EP EP94926898A patent/EP0669843A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH667210A5 (en) * | 1981-11-24 | 1988-09-30 | Meguer V Kalfaian | Electromagnetic radiation device for therapeutic purposes. |
US4611599A (en) * | 1983-06-16 | 1986-09-16 | Richard Hugh Cameron Bentall | Electrical apparatus for influencing the metabolic characteristics of living systems |
EP0136530A1 (en) * | 1983-09-12 | 1985-04-10 | Dieter-Ernst Broers | Irradiation device for treating living tissue with electro-magnetic waves |
EP0500983A1 (en) * | 1991-02-28 | 1992-09-02 | Medi-Line Gmbh | Irradiation device for treating living tissue with electro-magnetic waves |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997013549A1 (en) * | 1995-10-10 | 1997-04-17 | Suleyman Seckiner Gorgun | Device and process for the modulation of the biological functions of biological structures |
AU751973B2 (en) * | 1997-10-17 | 2002-09-05 | Axel Muntermann | Device for magnetic field therapy |
WO2001070334A1 (en) * | 2000-03-24 | 2001-09-27 | Active Medical Devices S.A. | Equipment designed to stimulate and optimise the biomolecular and cellular reorganization |
FR2820327A1 (en) * | 2001-02-06 | 2002-08-09 | Mohamed Ayari | PROCESS FOR OBTAINING A SET OF ELECTROMAGNETIC FIELDS WITH DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND BIOTECHNOLOGICAL VIEWS |
WO2002062418A1 (en) * | 2001-02-06 | 2002-08-15 | Mohamed Ayari | Electromagnetic set for , diagnostic, preventive, therapeutic purposes |
WO2019178704A1 (en) * | 2018-03-20 | 2019-09-26 | Novatech - Solutions Sa | Equipment designed to stimulate and optimize the bio-molecular and cellular reorganization |
Also Published As
Publication number | Publication date |
---|---|
EP0669843A1 (en) | 1995-09-06 |
AU7655894A (en) | 1995-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1575475B1 (en) | Regulation of type ii collagen gene expression using specific and selective electrical and electromagnetic signals | |
Berta et al. | Extracorporeal shock waves enhance normal fibroblast proliferation in vitro and activate mRNA expression for TGF-β1 and for collagen types I and III | |
EP1560553B1 (en) | Regulation of aggrecan gene expression using specific and selective electrical and electromagnetic signals | |
CA2622143A1 (en) | Integrated coil apparatus and method for using same | |
CA2367631A1 (en) | Wireless cardiac pacing system with vascular electrode-stents | |
EP1702648A3 (en) | System of implantable devices for monitoring and/or affecting body parameters | |
CA2308335A1 (en) | Device for magnetic field therapy | |
ATE477018T1 (en) | DEVICE FOR ULTRASONIC AND ELECTROMAGNETIC TREATMENT OF TISSUE | |
Pilla et al. | Bioeffects of weak electromagnetic fields | |
NZ548447A (en) | Up-regulation of bone morphogenetic protein (BMP) gene expression in bone cells by electromagnetic signals | |
DE69716596D1 (en) | DEVICE FOR IONTOPHORETIC ADMINISTRATION OF DRUGS WITH A TASK STIMULATION GENERATOR | |
WO1995007729A1 (en) | Device for stimulating the natural defenses of a person or of any cellular system | |
WO1997011667A3 (en) | Therapeutic applications using horse serum | |
AU6567494A (en) | Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use | |
WO2019178704A1 (en) | Equipment designed to stimulate and optimize the bio-molecular and cellular reorganization | |
张锦珠 et al. | Research on cell communication of P. elegans by means of photon emission | |
AU4749900A (en) | Inactivated microorganisms comprising soluble and/or solubilizable substances having pharmacological activity and/or nutritional substances having pharmacological activity, the process for their preparation and their uses thereof | |
Laroussi et al. | Biochemical pathways in the interaction of non-equilibrium plasmas with bacteria | |
WO2001070334A1 (en) | Equipment designed to stimulate and optimise the biomolecular and cellular reorganization | |
US20080021526A1 (en) | Electromagnetic Treatment of Mammals | |
WO1993025576A3 (en) | Peptides having platelet-derived growth factor (pdgf) activity | |
Adams et al. | Peeper creepers. | |
Butz | Agriculture and Politics in the 1980's | |
McLeod | Low frequency electromagnetic energy: its emergence as a medical treatment | |
McKernan | The real war on drugs. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994926898 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1994926898 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994926898 Country of ref document: EP |